SEXUAL
FUNCTION AND SEX HORMONES IN WOMEN WITH PREMATURE MENOPAUSE
Jorge
Luis Sell Lluveras, MD[1];
Rubén Salvador Padrón Durán, MD[2]
Caridad Teresita García Álvarez, BS[3]
Eng. Franz Torres Barbosa, MS.[4]
ABSTRACT:
Sexual function in women with normal menopause has been
extensively dealt with in specialized literature worldwide.
However, no specific study has been reported on this subject
regarding women with premature menopause. Our study was
conducted aimed at characterizing sexual function, as well
as its possible correlation with sex hormones, in women
with premature menopause (PM). Participants included all
patients diagnosed in our center with this condition and
who were willing to participate in the study (a total of
31). Two questionnaires were applied with the purpose of
gathering general data and assessing sexual function. In
our study, we included both iatrogenic (IPM) and non-iatrogenic
(NIPM) premature menopause. Furthermore, we carried out
an exploratory analysis of sexual function and sex hormone
variables, and determined the correlation among variables
in each set separately, using the Spearman and Pearson coefficients;
and between both variable sets, using multiple correlation
technique. Results show that most women with premature menopause
did not suffer from any significant sexual dysfunction,
which was corroborated by their high incidence of orgasm
satisfaction and active sexual life, as well as a low incidence
of dyspareunia and reduced sexual desire. These women seldom
judged their sexual relations and their relation with their
partners as unsatisfying.
As indicated by our results, sexual satisfaction can serve
as a major conclusive indicator in the assessment of sexual
function. Sexual dysfunctions were frequent in women with
iatrogenic premature menopause, although not in all. We
also found that sexual life disorders depended relatively
often not only on the women, but also on their sexual partners.
Furthermore, we found that some sex hormones, such as testosterone
and dehydroepiandosterone sulfate (DHEAs), have an influence
on sexual function, but are not major determinants. In summary,
the low prevalence of sexual dysfunction found in women
with premature menopause indicates that biological-hormonal
factors have an effect on, but do not determine, this type
of disorder.
Introduction
Sexual
functioning is the ultimate expression of functional and organic
integrity of the neuro-endocrine and reproductive systems-the
apparatus that permits the body’s response during sexual activity.
Sexual response is also influenced by several psychological,
socio-cultural and biological factors, favored by some of
these, and inhibited by others.1, 2
The
study of sexual function was taboo in the past. It was only
after 1966, when Master and Johnson3 published
a fully scientific study--Human Sexual Response--that
we begin to see significant contributions in this field. Scientific
studies have revealed six major sexual dysfunction categories:
sexual desire disorders, orgasmic disorders, genital pain
disorders, non-specified sexual disorders (anesthesia with
orgasm, and genital pain during non-coital activities), lack
of pleasure during intercourse, and loss of sexual satisfaction.4
Moreover, researchers have gone into greater depth on the
physical and pathological aspects of sexual functioning. Special
interest has been given to the study of sexual function during
postmenopause, mainly to its link with sex hormones.
The
production of ovarian hormones declines during postmenopause.
A prolonged deprivation of estrogens has been associated with
cervical atrophy, reduced production of mucus, atrophic changes,
and reduced vaginal lubrication, which can bring about dyspareunia,
vaginitis, or vaginismus. These changes can reduce sexual
satisfaction and lead to secondary sexual dysfunctions.
Changes
in sensory perception, systemic blood flow and muscular contractility,
are among the extragenital manifestations of postmenopause.
The decline in the production of androgens often negatively
affects sexual desire, sexual fantasies, excitation, and sexual
satisfaction.5-12 However, not all menopausal women
undergo these changes, and their intensity can vary from one
woman to another. What’s more, many women do not develop any
sexual dysfunction during this phase of their life.13,14
The
factors that contribute to the sexual changes that take place
during climacterium, and the suspected role of hormones in
these changes, have not yet been elucidated.15,16
Age could be part of the answer. As women advance in age,
they experience a slow progressive decline in the intensity
of their sexual response, thus requiring more direct and prolonged
stimulation than when they were younger. Furthermore, circulatory
and organic functions in general are better in younger women.
Psychological factors also change with age.15
Although
ongoing, the study of sexual function has largely been carried
out in women with normal menopause. However, specialized literature
worldwide does not include specific studies on the sexual
function of women with premature menopause, also termed post-pubertal
premature ovarian failure-the cessation of the menstrual cycles
before age 40.17-19 Sexual behavior and response,
mental status, and organic function and structure change with
age. Aware of the fact that normal postmenopausal women experience
changes in their sexual life, which may vary in intensity
and form from one woman to another, and that a number of them
do not develop sexual dysfunctions despite the decline in
ovarian hormone production, we consider it important to investigate
the characteristics of sexual functioning in premature menopausal
women as well as the role of sex hormones in this phase of
a woman’s life.
Methods
Our
study included all women under 40 years of age who were being
seen at the Cuban Institute of Endocrinology for one year
due to secondary amenorrhea and elevated serum levels of follicle-stimulating
hormone (FSH) and luteinizing hormone (LH) ¥ 40 UI/L, at least
on two occasions, and who voluntarily agreed to participate
in our study. We excluded those who had received hormonal
treatment in the previous three months, those with mild or
severe psychiatric disorders, and those with chronic systemic
disorders or secreting pituitary tumors. Patients who were
eligible for our study (31) were given two questionnaires.
Questionnaire
No. 1:
This included five sections: (A) General Data, (B) Lifestyle,
(C) OB-GYN History, (D) Past Medical History, and (E) Comprehensive
Physical Examination.
Questionnaire
No. 2:
This questionnaire was designed at the Cuban Institute of
Endocrinology to evaluate sexual response, and modified for
use in our study. It consists of 11 questions-each having
several items-aimed at obtaining subjective information regarding
degree of sexual satisfaction, as well as objective difficulties
in engaging in an appropriate sexual relationship. Answers
to these questions reveal the existence or non-existence of
sexual dysfunctions in women and their sexual partners. This
questionnaire also explores sexual desire and sexual fantasies,
the existence of vaginal dryness, frequency of sexual relations,
and onset of any existing disorder.
The
description of sexual functioning was based on whether the
cause of premature menopause was iatrogenic or non-iatrogenic,
although we did not intend to establish comparisons between
these two groups given the limited number of cases with iatrogenic
premature menopause. However, we did establish differences
between them based on our awareness of the particular characteristics
of sexual function and hormones in women with iatrogenic premature
menopause.4
Serum
levels of sex hormones were measured using radioimmunoassay
methods.
Statistical
Analysis
An
exploratory analysis was conducted of two sets of variables:
sexual function variables (sexual intercourse, lack of or
decreased sexual desire, dyspareunia, vaginal dryness, erotic
fantasies, frequency of sexual relations, and sexual satisfaction)
and sex hormone variables (FSH, prolactin-PRL, estradiol-E2,
T, androstenedione-A’dione, dehydroepiandrosterone-DHEA, and
dehydroepiandosterone sulfate-DHEAs).
The
correlation among variables in each set (sexual function variables
and sex hormones variables) was calculated using the Spearman
and Pearson lineal correlation coefficients, respectively
(significant correlation was considered at significance level
< 0.05). We also calculated the correlation among all variables
together, 20 using the multiple correlation technique-a
very useful technique in the assessment of lineal and non-lineal
associations among sets of variables. This technique is based
on the calculation of the main overall dispersion components
of all variables according to their profiles and frequencies.
For
statistical calculations and elaboration of graphs, the SPSS
(version 8.0) and the SPAD (version 3.0) computer systems
were utilized.
Ethical
Aspects
To
obtain the participants’ informed consent, we explained the
objectives and general procedures of our research to them
as well as their right to drop out at any given moment with
no ensuing change in the quality of the medical care they
would continue to receive. Our study did not endanger the
participants’ life nor worsened their health condition; therefore,
we did not violate ethical norms or individual human rights.
The questionnaires and clinical and laboratory exams used
in our study contributed to a better understanding of the
patients’ clinical record and situation, thus improving their
treatment and health.
Results
The
description of sexual function was carried out based on whether
the cause of premature menopause was iatrogenic or non-iatrogenic.
The analysis of specific problems affecting sexual relations
showed that the number of women with iatrogenic premature
menopause who had never reached orgasm was equal to the number
of these women who had always reached orgasm (25% respectively).
The majority of women with non-iatrogenic premature menopause
referred to have always or almost always reach orgasm during
sexual intercourse (51.8%). Only a small percentage of them
(11.1%) reported never experiencing orgasm. Three fourths
of women with iatrogenic premature menopause reported a decrease
in or lack of sexual desire. However, approximately the same
amount of those with non-iatrogenic premature menopause (77.8%)
reported no alteration in this respect. A similar pattern
was found for dyspareunia. Most women with iatrogenic premature
menopause reported to suffer from this disorder (75%); in
contrast, the majority of women with non-iatrogenic premature
menopause did not report important alterations (85.2%). The
majority of women with iatrogenic premature menopause (75%),
and approximately half of those with non-iatrogenic premature
menopause (48.1%), reported to have erotic dreams. Moreover,
the majority of women in both groups did not report vaginal
dryness (75% and 59.3%, respectively) (Table 1).
Table 1. - Distribution of Women
with Iatrogenic and Non-iatrogenic PM* According to Characteristics
of Sexual Function Variables
| Characteristics
of Sexual Function Variables |
Iatrogenic |
Non-iatrogenic |
| |
N=4 |
% |
N=27 |
% |
| Orgasm
1. Always
2. Almost always
3. Sometimes
4. Almost never
5. Never |
|
|
|
|
| Decreased
Sexual Desire
1. Always
2. Almost always
3. Sometimes
4. Almost never
5. Never |
|
|
|
|
| Dyspareunia
1. Always
2. Almost always
3. Sometimes
4. Almost never
5. Never |
|
|
|
|
| Erotic
Fantasies
1. Yes
2. No |
|
|
|
|
|
Vaginal Dryness
1. Yes
2. No |
|
|
|
|
* Premature Menopause
The
analysis of the frequency of sexual relations showed that
50% of women with iatrogenic premature menopause had sexual
relations with an average frequency while the other 50% reported
a frequency of 2-4 times a month. The majority of women with
non-iatrogenic premature menopause (59.3%) reported an average
frequency in their sexual relations, while 40.7% of them reported
a frequency of 4 times a month (Table 2).
Table 2. - Distribution
of Women with Iatrogenic and Non-iatrogenic PM* According
to the Frequency of Sexual Intercourse
|
Frequency of Sexual Intercourse |
Iatrogenic |
Non-iatrogenic |
|
|
N=4 |
% |
N=27 |
% |
|
Twice a month
Once a week ·
Two to three times a week ·
More than three times a week |
1
1
2
- |
25
25
50
- |
3
8
12
4 |
11.1
29.6
44.5
14.8 |
* Premature Menopause
As
to the degree of satisfaction during sexual intercourse, 25%
of women with iatrogenic premature menopause reported satisfaction,
while over half of those with non-iatrogenic premature menopause
evaluated their satisfaction as adequate; 25.9% considered
it as very satisfying, 37.1% as satisfying and only 7.4% as
unsatisfying. None evaluated their relations as very unsatisfying.
In relation with our participants’ general assessment of their
relation with their partner, only 25% of those with iatrogenic
premature menopause considered them as satisfying, and 75%
as average or unsatisfying (50% and 25% respectively). The
majority of non-iatrogenic menopausal women considered their
relation with their partner as very satisfying (25.9%) or
satisfying (48.1%), while only 3.85% considered them as unsatisfying
(Table 3). None of our participants considered their
relation with their partner as very unsatisfying.
Table 3. - Distribution
of Women with Iatrogenic and Non-iatrogenic PM* According
to their Assessment of their Sexual and Partner Relationships
|
Sexual Relationships |
Iatrogenic |
Non-iatrogenic |
| |
N=4 |
% |
N=27 |
% |
| Very
satisfying
Satisfying
Moderately satisfying
Unsatisfying |
-
1
3
- |
-
25
75
- |
7
10
8
2 |
25.9
37.1
29.6
7.4 |
|
Partner
Relation |
|
|
|
Very
satisfying
Satisfying
Moderately satisfying·
Unsatisfying |
-
1
2
1 |
-
25
50
25 |
7
13
6
1 |
25.9
48.1
22.2
3.8 |
*Premature Menopause
We
also found that sexual life disorders in these women are frequently
caused not only by them but by their partners as well. Of
those who reported difficulties with their partner, 9.6% considered
that the cause was their partner’s fault and 33.3% considered
that it was caused by both.
The
correlation analysis among sexual function variables showed
that erotic fantasies were not correlated with any other variable.
We also found that the degree of sexual satisfaction was lineally
correlated with the rest of the sexual function variables;
i.e., the higher the incidence of declined sexual desire,
dyspareunia and vaginal dryness, and the lower the frequency
of orgasms and sexual intercourse, the lower the degree of
satisfaction, and vice versa. Declined sexual drive, dyspareunia,
vaginal dryness, and low frequency of orgasm are inter-correlated:
the first three in a positive way among them, while their
correlation with the frequency of orgasms was negative. No
lineal correlation found between the frequency of sexual intercourse
and dyspareunia, orgasm or vaginal dryness (Table 4).
Table 4. - Spearman Correlation Coefficients
Among Sexual Function Variables
|
|
Decreased
Sexual Desire |
Dyspareunia |
Orgasm |
Vaginal
Dryness |
Erotic
Fantasies |
Frequency
of Sexual Relations |
|
Decreased
Sexual Desire |
|
|
|
|
|
|
|
Dyspareunia |
0.588** |
|
|
|
|
|
|
Orgasm |
-0.665** |
-0.713** |
|
|
|
|
|
Vaginal
Dryness |
0.698** |
0.565** |
-0.749** |
|
|
|
|
Erotic
fantasies |
-0.036 |
0.044 |
0.126 |
-0.158 |
|
|
|
Frequency
of Sexual Relations |
0.478** |
0.233 |
-0.271 |
0.352 |
0.079 |
|
|
Satisfaction
During Sexual Relations |
-0.609** |
-0.476** |
0.689** |
-0.654** |
0.219 |
-0.584** |
**p< 0.05
Table
5 shows the correlation among sex hormones
studied in the total group of patients.. We found a positive
correlation between T and A’diona (p=0.039), T and DHEAs (p=0.028),
A’diona and DHEA (p=0.049), as well as between DHEA and DHEAs
(p=0.001).
Table 5. - Pearson Correlation Coefficients Among Sex Hormones
in Women with PM*
| |
PRL |
E2 |
T |
Adiona |
DHEA |
|
E2 |
0.133 |
|
|
|
|
|
T |
-0.194 |
0.190 |
|
|
|
|
A´diona |
-0.482** |
0.069 |
0.373** |
|
|
|
DHEA |
-0.113 |
0.224 |
0.309 |
0.356** |
|
|
DHEAs |
-0.260 |
0.044 |
0.396** |
0.330 |
0.587** |
*Premature Menopause** p< 0.05
There
is also a negative correlation between PRL and A’diona(p=0.006)
Figure
1 shows the interrelation among sexual function
variables, which were categorized using the multiple correspondence
technique. We found correlation among vaginal dryness, dyspareunia,
reduction or loss of sexual desire, sexual satisfaction and
general satisfaction with couple relations; i.e., the lower
the incidence of vaginal dryness (2), the lower the incidence
of dyspareunia (5) and the lower the incidence of reduced
or loss of sexual desire (5); while the higher the incidence
of sexual satisfaction (1), the higher the degree of general
satisfaction with couple relations (1). However, orgasm and
frequency of sexual intercourse did not show a complete lineal
association, as did the other variables. The existence of
erotic fantasies was not associated with the rest of the variables.
Figure 1.-Correlation Among Categorized
Sexual Function Variables and Sex Hormones (Multiple Correlation
Technique)

We
can easily distinguish two well-defined groups. To the right
side of the figure are those women with no sexual dysfunction;
i.e., those with no reduction or loss of sexual desire (5),
the ones that had always reached orgasms (1), the ones who
reported no dyspareunia (5), the ones that did not have vaginal
dryness (2), the ones with the highest frequency of sexual
intercourse (5), and those who felt very satisfied during
sexual intercourse (1) and with their couple in general (1).
To the left side of the figure are the women who reported
just the opposite (the ones who felt unsatisfied).
The
correlation analysis between sex hormone and sexual function
variables showed a strong positive association between sexual
satisfaction and serum levels of androgens (mainly T and DHEAs).
The degree of association is marked in the figure by the length
of the arrows. The rest of the hormones did not show any association
with the sexual function variables (Figure 1).
Discussion
Sexual
function in young women with premature menopause resembles,
to some extent, that of women with normal postmenopause. Most
of them have a certain degree of difficulty in their sexual
relations with their couple; but the frequency, intensity,
and repercussion of these difficulties differ greatly from
the ones described in women with normal postmenopause.
To
analyze the characteristics of sexual function in these patients,
we took into consideration whether the cause of their premature
menopause was iatrogenic or non-iatrogenic, although the number
of cases with iatrogenic premature menopause was too limited
to reach a conclusion. The majority of the women with iatrogenic
premature menopause reported difficulties in their sexual
relations, specifically in reaching orgasm; they had reduced
or loss of sexual desire, and dyspareunia. This coincides
with what has been described by Heiman and Meston4,
who say that sexual dysfunction symptoms and signs in women
with iatrogenic premature menopause are more acute and intense
than the ones found in women with normal menopause, and that
this has been associated with an abrupt decline in the production
of ovarian hormones. However, the majority our participants
reported erotic fantasies and did not complain about vaginal
dryness. Moreover, the majority of those with non-iatrogenic
premature menopause showed no sexual dysfunction.
These
outcomes are explained by the fact that in this study, sexual
desire, dyspareunia, orgasm and vaginal dryness were found
to be lineally correlated, while erotic fantasies were expressed
as an independent variable. Nevertheless, despite the existing
correlation, a variable can sometimes show unexpected behavior,
as is the case of vaginal dryness in patients with iatrogenic
premature menopause. This demonstrates that under certain
circumstances a given factor can predominantly influence and
modify one aspect of sexual function. Continual sexual activity
is known todiminish vaginal dryness.13,21 In our
study, a strong lineal correlation between these variables
did not exist; however, a correlation, although not lineal,
was found when we used the multiple correlation technique.
Most patients maintained a regular and continual sexual activity,
which explains the low incidence of vaginal dryness in both
groups. It has been stated that the mechanic activity of sexual
relations and the absorption of prostaglandins from prostatic
secretions during coitus causes vasodilatation, which favors
local vaginal circulation and propitiates transudation in
local blood vessels. This fluids ensure vaginal lubrication.13,21
The
great majority of participants with non-iatrogenic premature
menopause considered that their relation with their partner
was, in general, satisfying, which was strongly correlated
with their degree of sexual satisfaction. This suggests that
understanding, communication, affection, and respect between
menopausal women and their partner have a positive impact
on their sexual functioning. A correlation between the degree
of satisfaction regarding couple relations and the degree
of sexual satisfaction was also observed in women with iatrogenic
premature menopause, most of whom evaluated their couple relations
as fair or unsatisfying, which greatly coincided with their
evaluation of their sexual relations.
We
must emphasize that in spite of the fact that 67.7% of our
participants (21 cases) admitted the existence of specific
difficulties in their sexual relations, the majority of them
evaluated them and, in general, the relationship with their
partner, as satisfying. Some of them considered that difficulties
such as the absence of orgasm and, sometimes, vaginal dryness,
did not have had an impact on their degree of satisfaction.
We
also found that sexual life disorders were often caused by
both members of the couple, although occasionally it was
exclusively caused by the man. This is a situation commonly
reported by premenopausal women.10,13
Age
is another important factor in sexual function and activity.
As we know, sexuality changes with age, each phase of life
being marked by specific characteristics. Therefore, it is
impossible to speak of sexuality irrespective of age without
making serious generalization mistakes.22
It
is a fact that the intensity of sexual response lowers with
age, and older women need a more direct and longer stimulation
to reach an appropriate degree of excitation and satisfaction.15
In older women, blood circulation declines 21,
as well as sexual desire, frequency of sexual activity and
orgasm.1,23 Some authors have associated this
with normal menopause24,25, while others have associated
them with age.26 Indications exist that the production
of adrenal androgens declines with age, regardless of the
onset of menopause.27,28 DHEA and DHEAs show a
negative correlation with age,29 and like the rest
of androgens, they have shown a correlation with desire, orgasm,
sexual satisfaction, and other sexual function variables.6,9,10,12
Nevertheless, this is not absolute. Some of these women struggle
for self-assertion and voluntarily increase the frequency
of their sexual relations, and succeed in reaching satisfaction.4,7,15
Whatever the impact of the variables initially considered,
our study has revealed that, in women with premature menopause
this impact is less significant than the one found in women
of advanced age-a finding not previously reported in medical
literature.
The
correlation between sexual function variables has already
been analyzed to some extent. It is important to add, however,
that the lack of correlation between erotic fantasies and
the rest of the variables can be easily explained by the fact
that erotic fantasies are strongly influenced and shaped by
attitudes and principles that result from the patient’s social
environment, by their individual way of perceiving, conceiving
and projecting sex, as well as by their previous experience.
Furthermore, the fact that the degree of sexual satisfaction
is correlated with the other sexual function variables makes
us consider it a sensitive indicator to characterize the overall
state of sexual function in these women.
A
lineal correlation among androgens was to be expected since
these substances share a common synthesis path: ovarian and
adrenal estrogenesis. The negative correlation between PRL
and A’diona is also easy to explain if we consider that PRL
inhibits the activity of the enzymes 3b-ol-dehydrogenase and
17,20 desmolase, which convert DHEA into A'diona, and 17-OH-Progesterone
into A'diona, respectively.
The
correlation analysis between sex hormones and sexual function
is remarkable. PRL has not been correlated with sexual dysfunctions28,
which coincides with the outcomes in our study. Hypoestrinism
has been associated with the decrease in vaginal lubrication,
the increase of dyspareunia, and the decrease in sexual satisfaction.4-9
Some authors5,30 have found that this correlation
occurs when the serum levels of E2 is lower than 35 pmol/L.
Our study did not show such a correlation. What’s more, of
eight patients with serum levels of E2 at 30 pmol/L, only
three had vaginal dryness, which means that 62.5% of patients
did not report this symptom. Furthermore, two of them reported
dyspareunia, and none of them was dissatisfied with their
sexual relations. This demonstrated that sexual function variables
were not influenced by the serum levels of 17-b-estradiol.
Serum
levels of androgens have been associated with the degree of
sexual desire, and with the frequency of sexual fantasies,
orgasm, sexual intercourse, as well as with the degree of
sexual satisfaction.7,8,12,31 A similar association
was found in our study. Androgens were also associated with
the lower incidence of vaginal dryness and dyspareunia, as
well as with the higher degree of general satisfaction with
couple relations. T and DHEAs were the sex hormones more highly
associated with sexual function. This association may be explained
by the fact that T is known to be the most potent of androgenic
hormones, and that DHEAs is the one which reaches the highest
serum levels, although it is not a potent androgen.
In
conclusion, our results indicate that the majority of young
women with premature menopause do not have major sexual dysfunctions,
which is corroborated by a high frequency of orgasm and sexual
relations as well as a low frequency of dyspareunia and reduction
of sexual desire. These women seldom evaluate their sexual
relations and the relation with their partner as unsatisfying.
The degree of sexual satisfaction can be considered as a sexual
function indicator in these patients. Sexual dysfunctions
are frequent in women with iatrogenic premature menopause,
although not in all of them. We also found that sexual life
disorders are often caused not only by the menopausal women
but by their partner. The social environment also influences
sexual functioning. Patients with a bigger work load have
orgasms more frequently. The low prevalence of sexual dysfunction
in these patients indicates that biological and hormonal factors
are important but not determinant. Psychosocial factors, age,
and general physical condition also seem to have an influence.
References
1. Hawton
K, Gath D, Day A. Sexual function in a community sample
of middle-age women with partners: effects of age, marital,
socioeconomic, psychiatric, gynecological, and menopausal
factors. Arch Sex Behav 1994;23:375-395.
2. Ballinger
S. Stress as a factor in lowered estrogen levels in the
early menopause. In: Multidisciplinary perspectives on
menopause. Ann NY Acad Sc 1990;592:95-113.
3. Master WH, Johnson VE. La
respuesta sexual humana. Ciudad de la Habana: Edit Científico
Técnica, 1981
4. Heiman JR, Meston CM. Evaluating sexual dysfunction in
women. Clin
Obstet Gynecol
1997;40:619-629.
5. McCoy
N L. Estrogen levels relation to self-reported symptoms
and sexuality in perimenopausal woman. In: Multidisciplinary
Perspectives on Menopause. Ann NY Acad Sc 1990;592:450-452.
6. Dennerstein
L, Dudley EC, Hopper TL, Burger H. Sexuality, hormones
and the menopausal transition. Maturitas 1997;26:83-93.
7. Bachmann
GA. Sexual function in Perimenopause. Obstet Gynecol
Clin N Am 1993;20:379-388.
8. Bachmann
GA. Influence of menopause on sexuality. Int J Fertil
Menopausal Stud 1995;40(Supp 1):16-22.
9. Boroditsky
RS, Saulnier L-A. 40-Something and Sexuality. J Soc
Obstet Gynecol Can 1994; Suppl 1:1-9.
10. Sarrel
PM. Sexuality and Menopause. Obstet Gynecol 1990;75:26s-30s
11.
Sulack PJ. The perimenopause: A critical time in a woman's
life. Int J Fertil 1996;41:85-89.
12.
Warnock JK, Bundren JC, Morris DW. Female hypoactive sexual
desire disorder due to androgen deficiency: clinical and
psychometric issues. Psychopharmacol Bull 1997;33:761-766.
13. Pearce MJ, Hawton K. Psychological and sexual aspects
of the menopause and HRT. Baillierès Clin Obstet Gynaecol
1997;10:385-399.
14. Bartlik B, Goldstein MZ. Maintaining sexual health after
menopause. Psychiatr
Serv 2000;51: 751-753.
15.
Meston CM. Aging and sexuality. West
J Med 1997;167:285-290.
16. McKinlay SM, Brambilla DJ, Posner JG. The normal menopause
transition. Maturitas 1997;14:103-115.
17.
de Moraes-Ruehsen M, Jones GS. Premature ovarian failure. Fertil Steril
1967;18:440-461.
18. Davis
SR. Premature ovarian failure. Maturitas 1996;23:1-8.
19. Lieman H, Santoro N. Premature ovarian failure: A modern
approach to diagnosis and treatment. The Endocrinologist 1997;7:314-321.
20.
Lebart L, Morineau A, Piron M. Statisque exploratoire multidimencionnelle. París:
Dunod, 1995.
21. Leiblum S, Bachmann G, Kemmen E. Vaginal atrophy in the
postmenopausal woman, the importance of sexual activity
and hormones. JAMA 1983;249:2195-2198.
22. López F, Fuentes A. Para comprender la sexualidad.
5ta edic.: Navarra: Edit Verbo Divino, 1994:7-16.
23. Osborn
M, Hawton K, Gath D. Sexual function among middle aged
women in the community. Brit Med J 1988; 296:959-962.
24.
Hunter MS. Emotional well-being, sexual behaviour and
hormone replacement therapy. Maturitas 1990;12:299-314.
25. McCoy NL, Davidson JM. A longitudinal study of effects
of menopause on sexuality. Maturitas 1985;7:203-210.
26.
Pfeiffer E, Davies CIC. Determinant of sexual behaviour in middle and old age. J Am Geriat
Soc 1972;20:151-158.
27.
Padrón RS, Lozano EE, Seuc A. Estudio clínico epidemiológico de los esteroides
sexuales y gonadotropinas en mujeres postmenopáusicas.
Endocrinología 1996;43:43-46.
28.
Vermeulen A, Verdonck L. Sex hormone status of the postmenopausal
women. Maturitas 1980;2:81-89.
29.
Meldrum DR, Davidson BJ, Tataryn IV, Judd HL. Changes
in circulating steroids with aging in postmenopausal women.
Obstet Gynecol 1981;57:624-628.
30.
Cutler WB, García CR, McCoy NL. Perimenopausal sexuality.
Arch Sex Behav 1987;16:225-234.
31.
Davis SR. The role of androgens and the menopause in female
sexual response. Int J Impot Res 1998;10 (Suppl
2):s82-s83.
|